251 related articles for article (PubMed ID: 32440848)
1. Smac mimetics can provoke lytic cell death that is neither apoptotic nor necroptotic.
Miles MA; Caruso S; Baxter AA; Poon IKH; Hawkins CJ
Apoptosis; 2020 Aug; 25(7-8):500-518. PubMed ID: 32440848
[TBL] [Abstract][Full Text] [Related]
2. Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-α and chemotherapeutic gemcitabine-induced necroptosis.
Akara-Amornthum P; Lomphithak T; Choksi S; Tohtong R; Jitkaew S
PLoS One; 2020; 15(1):e0227454. PubMed ID: 31914150
[TBL] [Abstract][Full Text] [Related]
3. Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells.
Gerges S; Rohde K; Fulda S
Cancer Lett; 2016 May; 375(1):127-132. PubMed ID: 26944210
[TBL] [Abstract][Full Text] [Related]
4. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
Hannes S; Abhari BA; Fulda S
Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809
[TBL] [Abstract][Full Text] [Related]
5. In vitro analysis reveals necroptotic signaling does not provoke DNA damage or HPRT mutations.
Miles MA; Hawkins CJ
Cell Death Dis; 2020 Aug; 11(8):680. PubMed ID: 32826875
[TBL] [Abstract][Full Text] [Related]
6. Smac mimetics in combination with TRAIL selectively target cancer stem cells in nasopharyngeal carcinoma.
Wu MS; Wang GF; Zhao ZQ; Liang Y; Wang HB; Wu MY; Min P; Chen LZ; Feng QS; Bei JX; Zeng YX; Yang D
Mol Cancer Ther; 2013 Sep; 12(9):1728-37. PubMed ID: 23699656
[TBL] [Abstract][Full Text] [Related]
7. IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis.
Perimenis P; Galaris A; Voulgari A; Prassa M; Pintzas A
BMC Cancer; 2016 Aug; 16():624. PubMed ID: 27520705
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis.
Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
[TBL] [Abstract][Full Text] [Related]
9. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.
Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S
Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Respiration and Mitochondrial Dynamics by SMAC-Mimetics for Combination Therapy in Chemoresistant Cancer.
Hagenbuchner J; Oberacher H; Arnhard K; Kiechl-Kohlendorfer U; Ausserlechner MJ
Theranostics; 2019; 9(17):4909-4922. PubMed ID: 31410190
[TBL] [Abstract][Full Text] [Related]
11. The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.
Matzinger O; Viertl D; Tsoutsou P; Kadi L; Rigotti S; Zanna C; Wiedemann N; Vozenin MC; Vuagniaux G; Bourhis J
Radiother Oncol; 2015 Sep; 116(3):495-503. PubMed ID: 26096848
[TBL] [Abstract][Full Text] [Related]
12. SMAC Mimetics Induce Autophagy-Dependent Apoptosis of HIV-1-Infected Resting Memory CD4+ T Cells.
Campbell GR; Bruckman RS; Chu YL; Trout RN; Spector SA
Cell Host Microbe; 2018 Nov; 24(5):689-702.e7. PubMed ID: 30344003
[TBL] [Abstract][Full Text] [Related]
13. Biomarker profile for prediction of response to SMAC mimetic monotherapy in pediatric precursor B-cell acute lymphoblastic leukemia.
Zinngrebe J; Schlichtig F; Kraus JM; Meyer M; Boldrin E; Kestler HA; Meyer LH; Fischer-Posovszky P; Debatin KM
Int J Cancer; 2020 Jun; 146(11):3219-3231. PubMed ID: 31749151
[TBL] [Abstract][Full Text] [Related]
14. IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα.
Shekhar TM; Miles MA; Gupte A; Taylor S; Tascone B; Walkley CR; Hawkins CJ
Oncotarget; 2016 Jun; 7(23):33866-86. PubMed ID: 27129149
[TBL] [Abstract][Full Text] [Related]
15. Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt's lymphoma cell lines.
Koch A; Jeiler B; Roedig J; van Wijk SJL; Dolgikh N; Fulda S
Neoplasia; 2021 May; 23(5):539-550. PubMed ID: 33971465
[TBL] [Abstract][Full Text] [Related]
16. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
17. LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signaling.
Bai L; McEachern D; Yang CY; Lu J; Sun H; Wang S
Cancer Res; 2012 Mar; 72(5):1229-38. PubMed ID: 22241084
[TBL] [Abstract][Full Text] [Related]
18. Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor α-induced necroptosis.
Laukens B; Jennewein C; Schenk B; Vanlangenakker N; Schier A; Cristofanon S; Zobel K; Deshayes K; Vucic D; Jeremias I; Bertrand MJ; Vandenabeele P; Fulda S
Neoplasia; 2011 Oct; 13(10):971-9. PubMed ID: 22028622
[TBL] [Abstract][Full Text] [Related]
19. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma.
Lomphithak T; Choksi S; Mutirangura A; Tohtong R; Tencomnao T; Usubuchi H; Unno M; Sasano H; Jitkaew S
Cell Commun Signal; 2020 Oct; 18(1):161. PubMed ID: 33036630
[TBL] [Abstract][Full Text] [Related]
20. SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent manner.
Greer RM; Peyton M; Larsen JE; Girard L; Xie Y; Gazdar AF; Harran P; Wang L; Brekken RA; Wang X; Minna JD
Cancer Res; 2011 Dec; 71(24):7640-8. PubMed ID: 22049529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
